Description

The global beta glucan market is poised to grow by US$ 215.7 million during 2022-2028, progressing at a CAGR of 6.7% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for beta glucan. The global beta glucan market is segmented on the basis of product type, source, end user, and region. By product type, the global beta glucan market has been segmented into insoluble, soluble. According to the research, the soluble segment had the largest share in the global beta glucan market. Based upon source, the global beta glucan market is categorized into cereals, fungi, others. On the basis of end user, the global beta glucan market has been segmented into food & beverages, nutraceutical supplements, others. Among these, the nutraceutical supplements segment was accounted for the highest revenue generator in 2021. Geographically, the global beta glucan market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The food & beverages market is further segmented into baked goods, beverages, confectionery, dairy, snacks, and others. StrategyHelix research indicates that the dairy segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the nutraceutical supplements market has been categorized into dietary supplements, and infant nutrition. Globally, the dietary supplements segment made up the largest share of the beta glucan market.

The global beta glucan market is highly competitive. The leading players in the beta glucan market include Ceapro Inc., Givaudan SA, Kemin Industries Inc., Kerry Group plc, Koninklijke DSM N.V. (Oatwell), Lallemand Inc. (Biotec BetaGlucans AS), Lantmannen Group, Ohly GmbH (ABF Ingredients Ltd.), Phileo by Lesaffre (Lesaffre Corporation), Super Beta Glucan (SBG) Inc., Vesta Pharmaceuticals Inc., Yaizu Suisankagaku Industry Co. Ltd. Competitive landscape gives a description of the competitive nature of the global beta glucan market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the beta glucan market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product type: insoluble, soluble
Source: cereals, fungi, others
End user: food & beverages, nutraceutical supplements, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Ceapro Inc., Givaudan SA, Kemin Industries Inc., Kerry Group plc, Koninklijke DSM N.V. (Oatwell), Lallemand Inc. (Biotec BetaGlucans AS), Lantmannen Group, Ohly GmbH (ABF Ingredients Ltd.), Phileo by Lesaffre (Lesaffre Corporation), Super Beta Glucan (SBG) Inc., Vesta Pharmaceuticals Inc., Yaizu Suisankagaku Industry Co. Ltd.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global beta glucan market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Beta glucan market overview
Part 3. Market breakdown by product type
– Insoluble
– Soluble
Part 4. Market breakdown by source
– Cereals
– Fungi
– Others
Part 5. Market breakdown by end user
– Food & beverages
– Nutraceutical supplements
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Ceapro Inc.
– Givaudan SA
– Kemin Industries, Inc.
– Kerry Group plc
– Koninklijke DSM N.V. (Oatwell)
– Lallemand Inc. (Biotec BetaGlucans AS)
– Lantmannen Group
– Ohly GmbH (ABF Ingredients Ltd.)
– Phileo by Lesaffre (Lesaffre Corporation)
– Super Beta Glucan (SBG) Inc.
– Vesta Pharmaceuticals, Inc.
– Yaizu Suisankagaku Industry Co., Ltd.
About StrategyHelix
Disclaimer